Dr. Angela Cano Yuste - Infectious DIseases - Best Researcher Award
Reina Sofia University Hospital/IMIBIC - Spain
Author Profile
Early academic pursuits 🎓
Angela Cano Yuste embarked on her academic journey at the Universidad de Córdoba, where she earned her degree in Medicine and Surgery in 2005. Driven by a passion for healthcare and community service, she further specialized in Family and Community Medicine at the Reina Sofia University Hospital, completing her training in 2010. Her quest for knowledge led her to pursue a Master’s in Research Methodology at the Universidad de Córdoba, which she completed in 2017. Angela’s academic achievements culminated in earning a Ph.D. in Medicine from the Biomedicine Program at the Universidad de Córdoba in 2023, solidifying her expertise in the field.
Professional endeavors 👨🌾
Angela’s professional career is marked by her dedication to both clinical practice and research. She began her career as an Emergency Physician at the Hospital de Montilla, serving from 2010 to 2018. In 2015, she joined FISEVI-FIBICO as an Investigator in the Infectious Diseases department, where she contributed significantly until 2021. Currently, Angela serves as a Specialist in Infectious Diseases at the Hospital Universitario Reina Sofia, a position she has held since 2021. Her role involves addressing complex infectious diseases, where she applies her extensive knowledge and experience to improve patient outcomes.
Contributions and research focus 🔧
Angela’s research is deeply rooted in the study and management of infectious diseases. Her work has primarily focused on complicated infections, including hospital-acquired pneumonia and Infectious DIseases infections caused by carbapenem-resistant Enterobacteriaceae. Angela has been instrumental as a Principal Investigator in several clinical trials, including those focused on complicated intra-abdominal infections in septic patients and interventional trials targeting hospital-acquired pneumonia and complicated infections. Her research efforts aim to advance the understanding and treatment of these critical conditions, contributing to better clinical practices and patient care.
Accolades and recognition 🌟
Throughout her career, Angela has garnered respect and recognition for her contributions to the field of infectious diseases. Her leadership in clinical trials and her commitment to advancing Infectious DIseases medical research have earned her accolades within the scientific and medical communities. Angela’s work in high-impact clinical studies reflects her dedication to improving healthcare outcomes through rigorous research and evidence-based practice.
Impact and influence 🌍
Angela’s impact extends beyond her immediate clinical and research responsibilities. Her work in infectious diseases has influenced treatment protocols and contributed to the global Infectious DIseases understanding of managing complex infections. Her research findings have helped shape strategies for combating antibiotic-resistant bacteria and improving patient care in hospital settings. Angela’s influence is evident in her contributions to medical literature and her role in guiding future research directions in infectious diseases.
Legacy and future contributions 🔄
Angela Cano Yuste’s legacy lies in her unwavering commitment to medical excellence and research innovation. As she continues her work at the Hospital Universitario Reina Sofia, Angela remains at the forefront of infectious disease research and clinical practice. Her future contributions are poised to further advance the field, particularly in developing new treatment protocols and managing emerging infectious threats. Angela’s dedication ensures that her impact will resonate within the medical community for years to come, inspiring future generations of healthcare professionals..
Notable publications
- Title: Invasive aspergillosis in liver transplant recipients in the current era
Authors: Kimura, M., Rinaldi, M., Kothari, S., Selzner, N., Husain, S.
Journal: American Journal of Transplantation, 2024, 24(11), pp. 2092–2107 - Title: Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital
Authors: López-Viñau, T., Muñoz-Rosa, M., Ruiz-Lara, L.M., Martínez-Martínez, L., Torre-Cisneros, J.
Journal: Antibiotics, 2024, 13(9), 792 - Title: Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study
Authors: Zhou, H., Buetti, N., Pérez-Galera, S., Ozakin, C., Layunta-Acero, R.
Journal: Journal of Antimicrobial Chemotherapy, 2024, 79(9), pp. 2132–2141 - Title: Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
Authors: López-Cortés, L.E., Delgado-Valverde, M., Moreno-Mellado, E., Díaz-López, M.D., Paño, J.R.
Journal: The Lancet Infectious Diseases, 2024, 24(4), pp. 375–385 - Title: Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)
Authors: Paniagua-García, M., Bravo-Ferrer, J.M., Pérez-Galera, S., Sahin, A., Akalin, H.
Journal: Clinical Microbiology and Infection, 2024, 30(2), pp. 223–230